All In MedTech

Investing and funding

Medtech due diligence with free public data: a checklist

A medtech due diligence checklist using free public data: FDA decisions, clinical trials, MAUDE reports, recalls, Medicare coverage, SEC filings and grants.

By the All In MedTech editorial team · Published November 19, 2026 · 6 min read

You can do a solid first pass of due diligence on a medical device company using free public records: FDA's clearance and approval databases for what it may market, ClinicalTrials.gov and published studies for its evidence, MAUDE and the recall database for its safety record, the Medicare Coverage Database for reimbursement, and SEC filings for its funding. The checklist below works through each source and the questions to ask of it.

This is a research method, not an investment view. Public data shows what has been filed, cleared, reported or disclosed. It cannot tell you whether a company will succeed or what it is worth, and it leaves out much of what a full diligence process would review.

The checklist at a glance

AreaKey questionFree sourceTool on this site
Regulatory statusWhat exactly is cleared or approved, and for what use?FDA 510(k), De Novo and PMA databasesDevice search, FDA decisions
FDA programsDoes the device have Breakthrough status?FDA Breakthrough Devices listBreakthrough Devices
Clinical evidenceWhat trials are registered and what has been published?ClinicalTrials.gov, PubMedTrials, Research
SafetyWhat adverse events and recalls are on record?MAUDE, FDA recall databaseMAUDE, company pages
ReimbursementIs there coverage, coding and payment?Medicare Coverage Database, CMS payment rulesReimbursement
FundingHow has the company been financed?SEC EDGAR (Form D, 10-K, 10-Q)Funding
Ownership and grantsWho holds large stakes, and which agencies fund it?Schedule 13D and 13G, NIH RePORTER, SBIR.govInvestors (paid tier)
NewsWhat has changed recently?Company releases, FDA announcementsNews

Step 1: Pin down the regulatory status

Start with FDA records, because the cleared or approved indication defines what the company can legally promote. For each product the company names, find the FDA decision and note:

  • the pathway: 510(k), De Novo or PMA, explained in 510(k) vs De Novo vs PMA,
  • the decision date and the applicant name on the record,
  • the product code and device class,
  • the indications for use as written in the decision summary or approval order,
  • for a 510(k), the predicate device it was compared to.

Compare the indications on record with the company's marketing claims. A gap between them is worth noting. Also check whether a product the company describes as "FDA approved" was in fact cleared through a 510(k), which is a different standard. The lookup itself is covered in how to check if a medical device is FDA cleared or approved.

For Class III devices, look at the PMA supplement history. A long series of supplements usually reflects design changes, manufacturing changes or new indications over time.

Step 2: Check the FDA program flags

Breakthrough Device designation signals that FDA agreed the device may offer more effective treatment or diagnosis of a life-threatening or irreversibly debilitating condition. It brings more interaction with FDA during review, and some Medicare pathways are limited to Breakthrough Devices. FDA publishes the list of designated devices only once they are authorized, so for a device still in development, rely on the company's announcement and look for confirmation later.

Step 3: Review the clinical evidence

Search ClinicalTrials.gov for the company as sponsor and for the device name. For each study, record its status, enrollment, primary endpoint and primary completion date, and whether results have been posted. Look for:

  • a pivotal study for a higher-risk device, since PMA devices usually need one,
  • terminated or withdrawn studies, which carry a short reason in the record,
  • changes to endpoints or completion dates over time, visible in the record history,
  • whether the patients enrolled resemble the population the company plans to sell to.

Then search published literature. Peer-reviewed results carry more weight than press releases or conference abstracts. How device trials are run under FDA rules is covered in Investigational Device Exemption (IDE).

Step 4: Read the safety record

Two FDA databases matter here. MAUDE holds medical device reports of deaths, serious injuries and malfunctions. The recall database lists recalls by class, with Class I being the most serious.

Read MAUDE carefully. Reports are not proof that a device caused harm, counts rise with sales volume, and reporting can spike after a recall or publicity. Use it to understand what kinds of problems are reported and whether they cluster, rather than to compare raw totals between companies. Background is in what is MAUDE, and recall classes are explained in medical device recalls explained.

For a fuller picture, FDA also publishes warning letters and inspection classifications on fda.gov. A warning letter about quality system problems can delay new clearances and approvals.

Step 5: Check reimbursement

FDA authorization does not mean anyone will pay for the device. Check three things:

  1. Coding: whether existing codes describe the procedure or the device, or whether new codes are needed.
  2. Coverage: whether Medicare has a national coverage determination or local coverage determinations that apply, searchable in the Medicare Coverage Database.
  3. Payment: whether the payment amount covers the cost of using the device, and whether add-on or pass-through payments apply.

A device with clear FDA status but no coverage path may face slow adoption. The framework is in how medical device reimbursement works, and the Reimbursement Pathway Explorer lists recent coverage decisions.

Step 6: Look at funding and ownership

For a public company, the annual report (10-K) and quarterly reports (10-Q) on SEC EDGAR give revenue, losses, cash and debt, along with risk factors that often name specific regulatory, reimbursement or supply risks. Compare cash on hand with recent spending to see how much runway the company says it has. Schedule 13D and 13G filings show holders above 5%.

For a private company, Form D filings show amounts sold in exempt offerings, the type of security and the number of investors. They do not name investors or give a valuation, and some rounds never produce a Form D. How to read them is in how to find a medtech company's funding with SEC Form D.

Grants are worth checking too. NIH RePORTER and SBIR.gov list federal awards, with abstracts that often describe a device before it reaches FDA. See SBIR and STTR grants for medical device companies.

Step 7: Reconcile and record

Keep a working table with one row per product and one column per source. Fill each cell from a record you can link, and leave a cell blank rather than estimating. Then look for disagreements:

  • products the company sells that have no FDA record under its name, which may be cleared under a partner or a former company name,
  • trials the company describes that are not registered,
  • safety signals the company's filings do not mention,
  • funding announced in the press with no matching Form D.

Each one has a possible innocent explanation, but each is a question to ask the company.

What public data leaves out

Public records do not include internal test reports, design history files, quality system audit results that FDA has not published, supplier and customer contracts, patent strategy, or most financial detail for private companies. Data also lags: FDA databases, MAUDE and SEC data sets update on their own schedules. Treat public data as the first layer of diligence, and confirm anything important with the company and the original source.

For background on funding stages and exits, see how investors invest in medtech.

Frequently asked questions

What should medical device due diligence check first?
Start with the company's FDA decisions, since the cleared or approved indications define what it can legally market, then check the clinical evidence, safety record, reimbursement and funding against what the company says.
Is there free data for researching a medical device company?
Yes. FDA's 510(k), De Novo, PMA, MAUDE and recall databases, ClinicalTrials.gov, the Medicare Coverage Database and SEC EDGAR are all free, and this site combines them on device and company pages.
Can public data replace full due diligence?
No. Public records leave out internal test data, quality system findings not yet published, contracts, intellectual property details and most private financial information, so they support diligence rather than replace it.
How do I find out how much a private device company has raised?
Look up its Form D filings on SEC EDGAR, which report amounts sold in exempt offerings, keeping in mind that not every round produces a Form D.

For information only, not medical, legal or investment advice. Facts about FDA, CMS and SEC rules are current as of the publication date; check the linked official source for changes.

Keep reading